Correlation Between Israel Opportunity and Medivie Therapeutic

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Israel Opportunity and Medivie Therapeutic at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Israel Opportunity and Medivie Therapeutic into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Israel Opportunity and Medivie Therapeutic, you can compare the effects of market volatilities on Israel Opportunity and Medivie Therapeutic and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Israel Opportunity with a short position of Medivie Therapeutic. Check out your portfolio center. Please also check ongoing floating volatility patterns of Israel Opportunity and Medivie Therapeutic.

Diversification Opportunities for Israel Opportunity and Medivie Therapeutic

-0.55
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Israel and Medivie is -0.55. Overlapping area represents the amount of risk that can be diversified away by holding Israel Opportunity and Medivie Therapeutic in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Medivie Therapeutic and Israel Opportunity is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Israel Opportunity are associated (or correlated) with Medivie Therapeutic. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Medivie Therapeutic has no effect on the direction of Israel Opportunity i.e., Israel Opportunity and Medivie Therapeutic go up and down completely randomly.

Pair Corralation between Israel Opportunity and Medivie Therapeutic

Assuming the 90 days trading horizon Israel Opportunity is expected to generate 0.37 times more return on investment than Medivie Therapeutic. However, Israel Opportunity is 2.67 times less risky than Medivie Therapeutic. It trades about -0.17 of its potential returns per unit of risk. Medivie Therapeutic is currently generating about -0.32 per unit of risk. If you would invest  7,820  in Israel Opportunity on September 3, 2024 and sell it today you would lose (500.00) from holding Israel Opportunity or give up 6.39% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Israel Opportunity   vs.  Medivie Therapeutic

 Performance 
       Timeline  
Israel Opportunity 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Israel Opportunity has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Israel Opportunity is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Medivie Therapeutic 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Medivie Therapeutic has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Israel Opportunity and Medivie Therapeutic Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Israel Opportunity and Medivie Therapeutic

The main advantage of trading using opposite Israel Opportunity and Medivie Therapeutic positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Israel Opportunity position performs unexpectedly, Medivie Therapeutic can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medivie Therapeutic will offset losses from the drop in Medivie Therapeutic's long position.
The idea behind Israel Opportunity and Medivie Therapeutic pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Other Complementary Tools

Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Stocks Directory
Find actively traded stocks across global markets